ReHeva Biosciences,Inc.
1 clinical trials · Sponsor
◉ Watch ReHeva Biosciences,Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer (NCT05580172) | ReHeva Biosciences,Inc. | 2022-06-01 |
Track ReHeva Biosciences,Inc. automatically
Every clearance here is in the API, with alerts when new ones post.